Rybelsus is a semaglutide drug made by Novo Nordisk. Although approved for diabetes treatment, Rybelsus is now widely used for weight loss similar to other drugs like Ozempic or Wegovy. New research has shown that using Rybelsus at higher dose levels for weight loss can cause a host of very serious health problems. Health conditions linked to Rybelsus include: gastroparesis or gastrointestinal conditions, including bowel obstruction or cyclic vomiting syndrome, and NAION vision loss.
If you used Rybelsus and suffered any of these health problems or injuries, you may be able to file a product liability lawsuit and get financial compensation. Our firm is currently accepting Rybelsus lawsuits from individuals with any of the following injuries:
- Vision loss from NAION (nonarthritic anterior ischemic optic neuropathy)